Terra Innovatum Added to Solactive Global Uranium & Nuclear Components Total Return Index, the Benchmark Tracked by the Global X Uranium ETF (URA)
Rhea-AI Summary
Terra Innovatum (NASDAQ: NKLR) announced that its common shares were added to the Solactive Global Uranium & Nuclear Components Total Return Index, effective at the open of trading on August 3, 2026. This index is the benchmark tracked by the Global X Uranium ETF (URA), a major uranium and nuclear sector ETF.
According to Terra Innovatum, inclusion in this rules-based index, administered solely by Solactive AG, places the company among global firms across the nuclear fuel cycle and expands its visibility to institutional, retail, passive, and thematic investors as it advances its SOLO™ micro-modular reactor program toward first-of-a-kind deployment.
Positive
- Added to Solactive Global Uranium & Nuclear Components Index effective August 3, 2026
- Included in benchmark tracked by Global X Uranium ETF (URA), increasing potential exposure to passive nuclear investors
- Recognition as commercial-stage micro-modular reactor developer within global nuclear fuel cycle peer group
Negative
- None.
Key Figures
Historical Context
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| Jul 23 | NRC readiness review | Positive | +1.5% | Requested voluntary NRC review of draft safety and environmental application sections. |
| Jul 20 | Commercial LOI correction | Positive | +12.0% | Selected SOLO platform for up to 8 MWe across Argentina and Brazil. |
| Jul 20 | Commercial LOI | Positive | +12.0% | Selected SOLO platform for up to 8 MWe across Argentina and Brazil. |
| Jul 07 | Turbine supply agreement | Positive | +2.2% | Secured long-term turbine and generator procurement for the Illinois FOAK reactor. |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
The four recent NKLR-specific news events in the available history all aligned with positive 24-hour price reactions.
Key Terms
total return index financial
micro-modular reactor technical
FOAK technical
LEU+ technical
HALEU technical
AI-generated analysis. How Rhea-AI works. Not financial advice.
Inclusion places Terra Innovatum among the global companies that define the nuclear fuel cycle, expanding access to passive and thematic nuclear investors
Index is tracked by the Global X Uranium ETF (URA), one of the largest dedicated uranium and nuclear sector ETFs
Addition reflects Terra Innovatum’s growing profile as a Nasdaq-listed, commercial-stage micro-modular reactor developer
NEW YORK, Aug. 05, 2026 (GLOBE NEWSWIRE) -- Terra Innovatum Global N.V. (“Terra Innovatum” or the “Company”) (NASDAQ: NKLR), a developer of micro-modular nuclear reactors, today announced that its common shares have been added to the Solactive Global Uranium & Nuclear Components Total Return Index, effective at the open of trading on Monday, August 3, 2026. The index is the benchmark tracked by the Global X Uranium ETF (NYSE Arca: URA), one of the largest exchange-traded funds providing investors with dedicated exposure to the uranium and nuclear sector.
As global demand for firm, carbon-free power accelerates, driven by AI infrastructure growth, data center expansion and industrial electrification, index inclusion extends Terra Innovatum’s visibility to a broader base of institutional and passive investors tracking the sector, in addition to the Company’s existing outreach to active, fundamental investors.
Alessandro Petruzzi, Co-Founder and Chief Executive Officer of Terra Innovatum, stated: “Being added to this index places Terra Innovatum alongside the companies that define the global nuclear fuel cycle, from uranium producers and enrichers to the next generation of reactor developers. It gives investors seeking exposure to the uranium and nuclear sector through passive and thematic strategies direct access to the SOLO™ story, and it reflects the progress we have made in the ten months since becoming a public company, from advancing our FOAK deployment in Illinois to securing the industrial supply chain needed to support it.”
Giordano Morichi, Founding Partner, Managing Director of Global Business Development and Investor Relations at Terra Innovatum, added: “Passive and thematic capital is an increasingly important source of demand for companies in our sector. Inclusion in the benchmark tracked by the Global X Uranium ETF (URA) expands Terra Innovatum’s visibility to a broad base of institutional and retail investors seeking exposure to the future of nuclear energy. As we continue advancing toward FOAK deployment and commercialization, this milestone further strengthens our positioning as a leading emerging commercial-stage micro-modular reactor developer within the global nuclear investment ecosystem.”
The addition was made in connection with the index’s ordinary adjustment, announced by Solactive AG on July 27, 2026, with the revised composition taking effect at the open on August 3, 2026. Solactive AG, headquartered in Frankfurt, Germany, is an independent index provider whose benchmarks serve as the basis for exchange-traded funds and other investment products worldwide. Index composition is determined solely by Solactive under its published, rules-based methodology.
ABOUT THE SOLACTIVE GLOBAL URANIUM & NUCLEAR COMPONENTS TOTAL RETURN INDEX
The index tracks companies across the global nuclear fuel cycle, spanning uranium mining and exploration, conversion and enrichment, nuclear component manufacturing, and reactor and fuel technology development. Index constituents include Cameco Corporation, Kazatomprom, BHP Group, NexGen Energy, Centrus Energy, Oklo Inc., NuScale Power, Lightbridge Corporation, X-Energy and Mitsubishi Heavy Industries, among others. Terra Innovatum’s addition places the Company inside the benchmark that investors use to obtain broad, passive exposure to the global nuclear sector.
ABOUT TERRA INNOVATUM & SOLO™
Terra Innovatum's mission is to make nuclear power accessible. We deliver simple and safe micro-reactor solutions that are scalable, affordable and deployable anywhere 1 MWe at a time. Terra Innovatum is a pioneering force in the energy sector, dedicated to delivering innovative and sustainable power solutions. Terra Innovatum plans to leverage cutting-edge nuclear technology through the SOLO™ Micro-Modular Reactor (SMR™) to provide efficient, safe, and environmentally conscious energy. With a mission to address global energy shortages, Terra Innovatum combines extensive expertise in nuclear industry design, manufacturing, and installation licensing to offer disruptive energy solutions. Committed to propelling technological advancements, Terra Innovatum and SOLO™ are dedicated to fostering prosperity and sustainability for humankind.
It is anticipated that SOLO™ will be available globally within the next three years. Conceptualized in 2018 and engineered over six years by experts in nuclear safety, licensing, innovation, and R&D, SOLO™ addresses pressing global energy demands with a market-ready solution. Built from readily available commercial off-the-shelf components, the proven licensing path for SOLO™ enables rapid deployment and minimizes supply chain risks, ensuring final cost predictability. Designed to adapt with evolving fuel options, SOLO™ supports both LEU+ and HALEU, offering a platform ready to transition to future fuel supplies.
SOLO™ will offer a wide range of versatile applications, providing CO2-free, behind-the-meter, and off-grid power solutions for data centers, mini-grids serving remote towns and villages, and large-scale industrial operations in hard-to-abate sectors like cement production, oil and gas, steel manufacturing, and mining. It also has the ability to supply heat for industrial applications and other specialized processes, including water treatment, desalination and co-generation. Thanks to its modular design, SOLO™ can easily scale to deliver up to 1GW or more of CO2-free power with a minimal footprint, making it an ideal solution for rapidly replacing fossil fuel-based thermal plants. Beyond electricity and heat generation, SOLO™ can also contribute to critical applications in the medical sector by producing radioisotopes essential for oncology research and cancer treatment.
To learn more, visit: investors.terrainnovatum.com.
Follow us on X: x.com/TerraInnovatum and
LinkedIn: www.linkedin.com/company/terra-innovatum-solo.
CONTACTS
Giordano Morichi
Founding Partner, Managing Director of Global Business Development & Investor Relations
Terra Innovatum Corp.
E: g.morichi@terrainnovatum.com
W: www.terrainnovatum.com
Simon Willcocks
Investor and Media Relations
Alliance Advisors IR
E: TerraIR@allianceadvisors.com
IMPORTANT INFORMATION FOR SHAREHOLDERS
This communication does not constitute an offer to sell or the solicitation of an offer to buy any securities or constitute a solicitation of any vote or approval.
FORWARD LOOKING STATEMENTS
The statements contained in this press release that are not purely historical are forward-looking statements. These forward-looking statements include, but are not limited to, statements regarding our expectations, hopes, beliefs, intentions or strategies regarding the future. In addition, any statements that refer to projections, forecasts or other characterizations of future events or circumstances, including any underlying assumptions, are forward-looking statements. The words “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “intends,” “may,” “might,” “plan,” “possible,” “potential,” “predict,” “project,” “should,” “would” and similar expressions may identify forward-looking statements, but the absence of these words does not mean that a statement is not forward-looking.
The forward-looking statements contained in this press release are based on our current expectations and beliefs concerning future developments and their potential effects on Terra Innovatum. There can be no assurance that future developments affecting Terra Innovatum will be those that we have anticipated. These forward-looking statements speak only as of the date this press release is delivered and involve a number of risks, uncertainties (some of which are beyond our control) or other assumptions that may cause actual results or performance to be materially different from those expressed or implied by these forward-looking statements. Should one or more of these risks or uncertainties materialize, or should any of our assumptions prove incorrect, actual results may vary in material respects from those projected in these forward-looking statements. Factors that may cause actual results to differ materially from current expectations include, but are not limited to: (1) the ability to recognize the anticipated benefits of the recently-completed Business Combination, which may be affected by, among other things, competition, the ability of the combined company to grow and manage growth profitably, maintain relationships with customers and suppliers and retain its management and key employees; (2) the risk that the recently-completed Business Combination disrupts current plans and operations of Terra Innovatum, including the expected timetable to achieve its expected commercialization of SOLO; (3) costs related to the completion of the Business Combination, including the costs of compliance with applicable securities laws; (4) changes in applicable laws or regulations; (5) the possibility that Terra Innovatum may be adversely affected by other economic, business, and/or competitive factors; (6) the ability of Terra Innovatum to meet stock exchange listing standards following the consummation of the Business Combination; (7) other risk factors described in the Company’s most recent Annual Report on Form 10-K and other documents subsequently filed with the Securities and Exchange Commission. In addition, there may be additional risks that Terra Innovatum does not presently know or that are currently believed to be immaterial, that could also cause actual results to differ from those contained in the forward-looking statements. Nothing in this communication should be regarded as a representation by any person that the forward- looking statements set forth herein will be achieved or that any of the contemplated results of such forward-looking statements will be achieved. You should not place undue reliance on forward-looking statements, which speak only as of the date they are made.
Neither Terra Innovatum nor any of its affiliates, officers, employees or agents, makes any representation or warranty, either express or implied, in relation to the fairness, reasonableness, adequacy, accuracy, completeness or reliability of the information, statements or opinions, whichever their source, contained in this press release or any oral information provided in connection herewith, or any data it generates and accept no responsibility, obligation or liability (whether direct or indirect, in contract, tort or otherwise) in relation to any of such information. Terra Innovatum and its affiliates, officers, employees and agents further expressly disclaim any and all liability relating to or resulting from the use of this press release and any errors therein or omissions therefrom.
In addition, the information contained in this press release is provided as of the date hereof and may change, and Terra Innovatum does not undertake any obligation to update or revise any forward- looking statements, whether as a result of new information, inaccuracies, future events or otherwise, except as may be required under applicable securities laws.
